What Apex Medical does

Apex Medical (顶点医疗器械（江苏）有限公司, Wuxi Apex Medical Co., Ltd.) is a privately held Chinese medical device company founded in 2006 and operating as a subsidiary of BASS Medical Group, headquartered in Wuxi with a sales and training center in Changzhou and a wholly-owned distribution subsidiary in Russia. The company focuses exclusively on diabetes therapy, manufacturing continuous subcutaneous insulin infusion (CSII) insulin pumps under the TruCare brand — marketed domestically as Zhikai (智凯) and HuiKai (慧凯) — across three generations (TruCare I, II, III), alongside a full ecosystem of proprietary consumables including soft cannula infusion sets (TCSF series), steel needle sets (TCS series), sterile drug reservoirs (TCC-I/II), and insertion devices. The third-generation TruCare III pump features microchip-controlled motor-driven drug delivery, BLE5.0 Bluetooth communication, an IP68 waterproof rating, basal rates up to 35 U/h with 0.025 U minimum bolus increment, and a bundled hospital management system. Apex holds NMPA Class III medical device registration in China, CE certification, ISO 13485, and German TUV laboratory validation, and is the only manufacturer in China with proprietary subcutaneous soft cannula production technology and with consumables compatible with imported insulin pumps.

The company generates revenue through three streams: (1) one-time hardware sales of TruCare insulin pump devices to hospitals, clinics, and patients; (2) recurring consumables sales of infusion sets and reservoirs on a razor/blade model; and (3) OEM/ODM contract manufacturing and technical support services for world-renowned pharmaceutical companies and medical institutions. Go-to-market is sales-led and enterprise-focused: direct field sales target hospitals and healthcare institutions, complemented by a proprietary international distribution network covering Italy, Austria, Russia, Turkey, Egypt, Greece, and India, plus a 2015 global strategic partnership with AIR LIQUIDE for international distribution and a 2016 domestic service platform agreement with VitalAire (including a TruCare pump rental service). Marketing is conducted primarily through medical conferences and academic events (CDS, CSE, EASD, ADA, CMEF) and clinical partnerships with hospitals. Pricing is quote-based and not publicly disclosed. Apex is venture-backed, having raised Series A from SIG (2013) and Series B from Qianhai Dayi (前海大一, 2015), with additional investment activity reported in 2014–2015; no further funding rounds are disclosed.

Name

Apex Medical

Legal name

顶点医疗器械（江苏）有限公司

Website

https://apexdiabetes.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

51–100 employees

Short description

Apex Medical is a Wuxi-based, BASS Medical Group subsidiary that designs, manufactures, and distributes TruCare-brand insulin pumps and proprietary consumables for diabetes therapy in China and 10+ international markets. It serves hospitals, clinics, and OEM/ODM pharmaceutical customers via direct sales, AIR LIQUIDE, and VitalAire channels.

Ownership category

akta.pro rank

Product category

Diabetes Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Insulin Pumps (Tubed) (HLAHAHAB)

akta.pro secondary industries

Insulin Pen Needles, Syringes & Infusion Sets (Consumables) (HLAHAHAE), Insulin Pumps & Patch Pumps (HLAHAIAG)

Keywords

• Insulin pump therapy
• Diabetes medical devices
• Continuous subcutaneous insulin infusion
• Insulin pump consumables
• OEM medical device manufacturing

Headquarters

HQ city

Wuxi Shi

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Insulin Pump Sales: Sale of TruCare I, II, III insulin pump devices to healthcare providers and patients
2. Consumables Sales: Recurring sales of infusion sets (steel needles, soft cannulas), reservoirs, and inserters as disposables for insulin pump users
3. OEM/ODM Services: Custom manufacturing and technical support services for world-renowned pharmaceutical companies and medical institutions

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels3 records

Core offering

Apex Medical designs, manufactures, and distributes insulin pump systems and supporting consumables for continuous subcutaneous insulin infusion (CSII) therapy used in diabetes treatment. The TruCare product family (智凯 and 慧凯 brands, generations I–III) is sold to hospitals, clinics, and patients in China and more than ten international markets, alongside proprietary soft cannulas, steel needle sets, drug reservoirs, and inserters. The company also provides OEM/ODM custom manufacturing services to global pharmaceutical companies.

Product overview

Apex Medical offers a comprehensive insulin delivery ecosystem consisting of two product lines: Zhikai (智凯) and Huikai (慧凯) insulin pumps under the TruCare brand, available in Type I, II, and III variants. The portfolio includes配套耗材 (supporting consumables) such as soft cannula infusion sets (TCSF series), steel needle sets (TCS series), drug reservoirs (TCC-I/II), and a Fast Settle Inserter for painless needle insertion. Products feature both fast connector and Luer connector interfaces for compatibility. The system provides continuous subcutaneous insulin infusion (CSII) therapy through basal rate and bolus delivery modes, with advanced models featuring Bluetooth connectivity, IP68 waterproof ratings, and hospital management system integration.

Differentiator

Problem solved

Functional benefit

Brands

• TruCare: Insulin pump brand including TruCare I, TruCare II, and TruCare III models. The TruCare III is the third-generation insulin pump with Bluetooth communication (BLE5.0), IP68 waterproof rating, and all-age suitability.
• 智凯
• 慧凯

Products and services

• 智凯 III 型胰岛素泵 (TruCare III Insulin Pump)

Quantifiable outcome

• 24-hour continuous micro-dose insulin infusion mimicking normal pancreatic function
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• AIR LIQUIDEcoreStrategic or Co-development Partner · 1 January 2016Global strategic partnership established for insulin pump distribution and service provision. AIR LIQUIDE provides international market access and service infrastructure.
• VitalAirecoreChannel Partner/ Reseller/ Distributor · 1 January 2016Domestic service platform cooperation for patient support, training, and device deployment in China. Includes TruCare Insulin Pump Rental Service.
• BASS Medical GroupcoreStrategic or Co-development Partner · 1 January 2011Parent company affiliation providing strategic direction and group resources for Apex Medical operations.
• Various World-Renowned Pharmaceutical CompaniesminorOEM/ Whitelabel/ Licensing PartnerOEM/ODM manufacturing services providing technical support and custom product development for pharmaceutical partners.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Terumo Corporation: Japanese medical device manufacturer with diabetes and drug delivery product lines. Comparable as an Asia-headquartered broad-incumbent with regulatory depth and hospital relationships across emerging markets.
• Roche Diabetes Care: Diabetes device franchise (Accu-Chek) within Roche. Comparable as a broad-incumbent diabetes hardware player with global distribution, though historically stronger in BGM than pumps; relevant for hospital-channel dynamics and reimbursement strategy.
• Medtronic: Global leader in insulin pump therapy via the MiniMed 780G AID system. Directly comparable as the dominant incumbent in the same diabetes device category Apex targets, though Medtronic operates at vastly larger scale and with closed-loop integration.
• Insulet Corporation: Maker of the Omnipod patch pump, the leading tubeless insulin delivery system. Competes in the same diabetes pump category but with a fundamentally different wearable, disposable form factor; relevant for benchmarking AID-capable pump economics.
• Tandem Diabetes Care: Maker of t:slim X2 insulin pump with Control-IQ AID algorithm. Competes directly in tubed insulin pump category with strong CGM-integration positioning; key benchmark for technology roadmap and ASP trends.

Direct peers

• Sooil Development: Korean manufacturer of Dana Diabecare insulin pumps, an Asian mid-tier competitor with similar tubed-pump technology and emerging-market distribution. Directly comparable in scale, pricing positioning, and geographic focus on Asia and Middle East.
• Ypsomed: Swiss manufacturer of the mylife YpsoPump, a tubed CSII insulin pump with European CE mark and broad European footprint. Closely comparable mid-tier pump maker competing for similar hospital and patient segments across Europe and emerging markets.
• Microtech Medical: Chinese manufacturer of the Equil patch pump and blood glucose monitoring systems. Most direct Chinese-headquartered competitor in insulin delivery, with overlapping hospital-channel GTM and shared regulatory pathway under NMPA.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Apex Medical